相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Comparative Metabolomics of Small Molecules Specifically Expressed in the Dorsal or Ventral Marginal Zones in Vertebrate Gastrula
Yukako Suzuki et al.
METABOLITES (2022)
Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?
Fangda Leng et al.
NATURE REVIEWS NEUROLOGY (2021)
Convergence: Lactosylceramide-Centric Signaling Pathways Induce Inflammation, Oxidative Stress, and Other Phenotypic Outcomes
Subroto Chatterjee et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Glucosylceramide in cerebrospinal fluid of patients with GBA-associated and idiopathic Parkinson’s disease enrolled in PPMI
Young Eun Huh et al.
npj Parkinsons Disease (2021)
Metabolomic Analysis of Small Extracellular Vesicles Derived from Pancreatic Cancer Cells Cultured under Normoxia and Hypoxia
Ryosuke Hayasaka et al.
METABOLITES (2021)
The Involvement of Lactosylceramide in Central Nervous System Inflammation Related to Neurodegenerative Disease
Wen Yu et al.
FRONTIERS IN AGING NEUROSCIENCE (2021)
Plasma lipidome is dysregulated in Alzheimer's disease and is associated with disease risk genes
Yue Liu et al.
TRANSLATIONAL PSYCHIATRY (2021)
\FTY720-Mitoxy reduces synucleinopathy and neuroinflammation, restores behavior and mitochondria function, and increases GDNF expression in Multiple System Atrophy mouse models
Guadalupe Vidal-Martinez et al.
EXPERIMENTAL NEUROLOGY (2020)
Immunomodulatory sphingosine-1-phosphates as plasma biomarkers of Alzheimer's disease and vascular cognitive impairment
Xin Ying Chua et al.
ALZHEIMERS RESEARCH & THERAPY (2020)
The Cross-Talk Between Sphingolipids and Insulin-Like Growth Factor Signaling: Significance for Aging and Neurodegeneration
Henryk Jesko et al.
MOLECULAR NEUROBIOLOGY (2019)
A metabolic profile of polyamines in parkinson disease: A promising biomarker
Shinji Saiki et al.
ANNALS OF NEUROLOGY (2019)
Four-repeat tauopathies
Thomas W. Roesler et al.
PROGRESS IN NEUROBIOLOGY (2019)
Plasma metabolite biomarkers for multiple system atrophy and progressive supranuclear palsy
Akio Mori et al.
PLOS ONE (2019)
DMS as an orthogonal separation to LC/ESI/MS/MS for quantifying isomeric cerebrosides in plasma and cerebrospinal fluid
Hongbin Xu et al.
JOURNAL OF LIPID RESEARCH (2019)
Extracellular -synuclein drives sphingosine 1-phosphate receptor subtype 1 out of lipid rafts, leading to impaired inhibitory G-protein signaling
Shaymaa Mohamed Mohamed Badawy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Sphingosine kinase 1/sphingosine-1-phosphate receptors dependent signalling in neurodegenerative diseases. The promising target for neuroprotection in Parkinson's disease
Joanna Motyl et al.
PHARMACOLOGICAL REPORTS (2018)
Linking Neuroinflammation and Neurodegeneration in Parkinson's Disease
Geraldine Gelders et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2018)
Particular CSF sphingolipid patterns identify iNPH and AD patients
Enrica Torretta et al.
SCIENTIFIC REPORTS (2018)
A Review of Gaucher Disease Pathophysiology, Clinical Presentation and Treatments
Jerome Stirnemann et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches
Adam L. Boxer et al.
LANCET NEUROLOGY (2017)
Metabolomic biomarkers as strong correlates of Parkinson disease progression
Peter A. LeWitt et al.
NEUROLOGY (2017)
Diagnosis and management of dementia with Lewy bodies Fourth consensus report of the DLB Consortium
Ian G. McKeith et al.
NEUROLOGY (2017)
Serum lipid alterations in GBA-associated Parkinson's disease
Leonor Correia Guedes et al.
PARKINSONISM & RELATED DISORDERS (2017)
Protein aggregation and neurodegeneration in prototypical neurodegenerative diseases: Examples of amyloidopathies, tauopathies and synucleinopathies
Mathieu Bourdenx et al.
PROGRESS IN NEUROBIOLOGY (2017)
High Performance Liquid Chromatography-Mass Spectrometry (LC-MS) Based Quantitative Lipidomics Study of Ganglioside-NANA-3 Plasma to Establish Its Association with Parkinson's Disease Patients
Jinzhi Zhang et al.
MEDICAL SCIENCE MONITOR (2017)
Elevated GM3 plasma concentration in idiopathic Parkinson's disease: A lipidomic analysis
Robin B. Chan et al.
PLOS ONE (2017)
Decreased long-chain acylcarnitines from insufficient β-oxidation as potential early diagnostic markers for Parkinson's disease
Shinji Saiki et al.
SCIENTIFIC REPORTS (2017)
Roles of tau protein in health and disease
Tong Guo et al.
ACTA NEUROPATHOLOGICA (2017)
The sphingosine-1-phosphate receptor 1 agonist SEW2871 reduces Tau-Ser262 phosphorylation in rat hippocampal slices
Frederic St-Cyr Giguere et al.
BRAIN RESEARCH (2017)
The Prevalence and Incidence of Dementia with Lewy Bodies: a Systematic Review
David B. Hogan et al.
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2016)
Autophagic lysosome reformation dysfunction in glucocerebrosidase deficient cells: relevance to Parkinson disease
Joana Magalhaes et al.
HUMAN MOLECULAR GENETICS (2016)
Neuroinflammation in Lewy body dementia
Ajenthan Surendranathan et al.
PARKINSONISM & RELATED DISORDERS (2015)
Sphingolipid Metabolism and Interorganellar Transport: Localization of Sphingolipid Enzymes and Lipid Transfer Proteins
Toshiyuki Yamaji et al.
TRAFFIC (2015)
Sphingomyelin SM(d18:1/18:0) is Significantly Enhanced in Cerebrospinal Fluid Samples Dichotomized by Pathological Amyloid-β42, Tau, and Phospho-Tau-181 Levels
Therese Koal et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Reduced glucocerebrosidase is associated with increased α-synuclein in sporadic Parkinson's disease
Karen E. Murphy et al.
BRAIN (2014)
PS Dependent APP Cleavage Regulates Glucosylceramide Synthase and is Affected in Alzheimer's Disease
Marcus O. W. Grimm et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2014)
Sphingolipid metabolites in inflammatory disease
Michael Maceyka et al.
NATURE (2014)
Loss of the neuroprotective factor Sphingosine 1-phosphate early in Alzheimer's disease pathogenesis
Timothy A. Couttas et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2014)
The global prevalence of dementia: A systematic review and metaanalysis
Martin Prince et al.
ALZHEIMERS & DEMENTIA (2013)
FTY720 (Fingolimod) Attenuates Beta-amyloid Peptide (Aβ42)-Induced Impairment of Spatial Learning and Memory in Rats
Masoumeh Asle-Rousta et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2013)
Parkinsonism syndrome in heterozygotes for Niemann-Pick C1
Hans H. Kluenemann et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2013)
α-Synucleinopathy phenotypes
Heather McCann et al.
PARKINSONISM & RELATED DISORDERS (2013)
Plasma Ceramide and Glucosylceramide Metabolism Is Altered in Sporadic Parkinson's Disease and Associated with Cognitive Impairment: A Pilot Study
Michelle M. Mielke et al.
PLOS ONE (2013)
A Multicenter Study of Glucocerebrosidase Mutations in Dementia With Lewy Bodies
Michael A. Nalls et al.
JAMA NEUROLOGY (2013)
Comparative Lipidomic Analysis of Mouse and Human Brain with Alzheimer Disease
Robin B. Chan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Guy M. McKhann et al.
ALZHEIMERS & DEMENTIA (2011)
Acid β-Glucosidase Mutants Linked to Gaucher Disease, Parkinson Disease, and Lewy Body Dementia Alter α-Synuclein Processing
Valerie Cullen et al.
ANNALS OF NEUROLOGY (2011)
Gaucher Disease Glucocerebrosidase and α-Synuclein Form a Bidirectional Pathogenic Loop in Synucleinopathies
Joseph R. Mazzulli et al.
CELL (2011)
Sphingolipid and Glycosphingolipid Metabolic Pathways in the Era of Sphingolipidomics
Alfred H. Merrill
CHEMICAL REVIEWS (2011)
Alzheimers Disease: Pathological Mechanisms and Recent Insights
Dana M. Niedowicz et al.
Current Neuropharmacology (2011)
Large-scale screening of the Gaucher's disease-related glucocerebrosidase gene in Europeans with Parkinson's disease
Suzanne Lesage et al.
HUMAN MOLECULAR GENETICS (2011)
α-Synuclein Interacts with Glucocerebrosidase Providing a Molecular Link between Parkinson and Gaucher Diseases
Thai Leong Yap et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Mice Lacking Major Brain Gangliosides Develop Parkinsonism
Gusheng Wu et al.
NEUROCHEMICAL RESEARCH (2011)
Lipid rafts: Keys to neurodegeneration
Cara-Lynne Schengrund
BRAIN RESEARCH BULLETIN (2010)
RCeveierwamide and ceramide 1-phosphate in health and disease
Lide Arana et al.
LIPIDS IN HEALTH AND DISEASE (2010)
Metabolomics tools for identifying biomarkers for neuropsychiatric diseases
Marlon P. Quinones et al.
NEUROBIOLOGY OF DISEASE (2009)
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
E. Sidransky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Second consensus statement on the diagnosis of multiple system atrophy
S. Gilman et al.
NEUROLOGY (2008)
Neurodegeneration associated with genetic defects in phospholipase A2
A. Gregory et al.
NEUROLOGY (2008)
Glucocerebrosidase gene mutation is a risk factor for early onset of Parkinson disease among Taiwanese
Yih-Ru Wu et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2007)
Cellular pathology in multiple system atrophy
Koichi Wakabayashi et al.
NEUROPATHOLOGY (2006)
Ganglioside GM3 is involved in neuronal cell death
Hosung Sohn et al.
FASEB JOURNAL (2006)
Epidemiology of Parkinson's disease
Lonneke M. L. de Lau et al.
LANCET NEUROLOGY (2006)
Sphingosine 1-phosphate and ceramide 1-phosphate: Expanding roles in cell signaling
CE Chalfant et al.
JOURNAL OF CELL SCIENCE (2005)
Analysis of the glucocerebrosidase gene in Parkinson's disease
C Sato et al.
MOVEMENT DISORDERS (2005)
Cell biology of protein misfolding: The examples of Alzheimer's and Parkinson's diseases
DJ Selkoe
NATURE CELL BIOLOGY (2004)
Accumulation and aggregation of amyloid β-protein in late endosomes of Niemann-Pick type C cells
T Yamazaki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
分享论文
